BMS Rare Heart Disease Drug 'Camzyos' Opens Prescription Path for Adolescents
The hypertrophic cardiomyopathy treatment drug 'Camzyos (generic name mavacamten)' is expected to be prescribed for adolescent patients as well.
Biowatch
HK Innoen's 'K-Cab' Applies for New Drug Approval from the U.S. FDA
HK Innoen announced on the 13th that its U.S. partner, Sevela Pharmaceuticals, a subsidiary and specialist in gastrointestinal medicines, submitted a...
SK Biopharm Receives FDA Approval for Clinical Trial Plan of Alpha-emitting Radiopharmaceuticals
SK Biopharm announced on the 12th that it has received approval from the U.S. Food and Drug Administration for the...
Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?
Denmark's Novo Nordisk's obesity drug ‘Wegovy Pill (ingredient name Semaglutide)’ has recently been launched in the U. S.
SK Bioscience Launches Quadrivalent Meningococcal Vaccine 'MenQuadfi' in Korea
SK Bioscience announced on the 9th that it has launched the quadrivalent meningococcal conjugate vaccine 'MenQuadfi' in...
Ligakem Bio Receives ADC Platform Technology Fees from Ono Pharmaceutical
Ligakem Bioscience announced on the 8th that it is set to receive milestone payments related to the development...
HK Innoen Launches Four New 'Zero Sugar' Condition Products
HK Innoen announced on the 7th that it will launch new hangover relief beverages, including three types of stick jelly...
Next-Generation Precision Medicine for Cancer Treatment... Amgen Acquires UK Biotech for 1 Trillion Won
Global pharmaceutical company Amgen is acquiring a UK biotech for up to $840 million (approximately 1.
Abl Bio Confirms Positive Effects of Cancer Drug 'ABL111' in Phase 1b Clinical Trial
Abl Bio announced on the 7th that it has confirmed positive anti-cancer efficacy in the dose expansion cohort of the...
Kangstem Biotech, 'Skin Organoid Source Technology' Registered Patent in Japan
Kangstem Biotech's technology related to skin organoids has been granted a patent in Japan.